Craneware plc (LON:CRW - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,968.90 ($26.64) and traded as high as GBX 2,100 ($28.41). Craneware shares last traded at GBX 2,060 ($27.87), with a volume of 16,729 shares traded.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on CRW shares. Shore Capital reaffirmed a "buy" rating on shares of Craneware in a research report on Thursday, May 8th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 2,800 ($37.88) target price on shares of Craneware in a research report on Tuesday, March 11th.
Read Our Latest Stock Report on Craneware
Craneware Stock Down 0.5%
The company's 50-day moving average is GBX 1,820.95 and its 200 day moving average is GBX 1,968.90. The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. The company has a market capitalization of £885.11 million, a PE ratio of 76.11 and a beta of 0.28.
Craneware Cuts Dividend
The business also recently declared a dividend, which was paid on Thursday, April 17th. Stockholders of record on Thursday, March 20th were issued a GBX 13.50 ($0.18) dividend. This represents a dividend yield of 0.71%. The ex-dividend date of this dividend was Thursday, March 20th. Craneware's payout ratio is presently 107.14%.
Insider Transactions at Craneware
In related news, insider Will Whitehorn purchased 1,911 shares of the business's stock in a transaction dated Thursday, April 24th. The shares were purchased at an average cost of GBX 1,584 ($21.43) per share, for a total transaction of £30,270.24 ($40,950.00). Company insiders own 19.28% of the company's stock.
About Craneware
(
Get Free Report)
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Craneware, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Craneware wasn't on the list.
While Craneware currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
